- Home
- MED vs PROC Comparison
MED vs PROC Comparison
Compare MED & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- PROC
- Stock Information
- Founded
- MED 1980
- PROC 1976
- Country
- MED United States
- PROC Luxembourg
- Employees
- MED N/A
- PROC N/A
- Industry
- MED Packaged Foods
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- PROC Health Care
- Exchange
- MED Nasdaq
- PROC Nasdaq
- Market Cap
- MED 213.6M
- PROC 203.1M
- IPO Year
- MED N/A
- PROC N/A
- Fundamental
- Price
- MED $19.16
- PROC $1.55
- Analyst Decision
- MED Hold
- PROC
- Analyst Count
- MED 1
- PROC 0
- Target Price
- MED $17.00
- PROC N/A
- AVG Volume (30 Days)
- MED 180.6K
- PROC 13.0K
- Earning Date
- MED 11-04-2024
- PROC 11-19-2024
- Dividend Yield
- MED 34.45%
- PROC N/A
- EPS Growth
- MED N/A
- PROC N/A
- EPS
- MED 0.67
- PROC 0.52
- Revenue
- MED $674,475,000.00
- PROC $414,096,000.00
- Revenue This Year
- MED N/A
- PROC $5.54
- Revenue Next Year
- MED N/A
- PROC $8.54
- P/E Ratio
- MED $28.78
- PROC $3.24
- Revenue Growth
- MED N/A
- PROC N/A
- 52 Week Low
- MED $17.07
- PROC $1.52
- 52 Week High
- MED $76.42
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- MED 54.65
- PROC 31.59
- Support Level
- MED $17.89
- PROC $1.70
- Resistance Level
- MED $21.08
- PROC $1.76
- Average True Range (ATR)
- MED 0.83
- PROC 0.09
- MACD
- MED 0.21
- PROC -0.03
- Stochastic Oscillator
- MED 50.13
- PROC 5.81
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.